Inside AAMI

Abstract

AAMI's Clinical Engineering Management Committee (CEMC) has expanded to include 10 new members to work on projects affecting clinical engineering managers around the world. They will tackle projects ranging from the development of competency guidelines for medical technology professionals to a book about biomed staffing.The new CEMC members include:More information about the CEMC can be found at www.aami.org/cemc.A revised AAMI standard offers device manufacturers new guidance on how to improve the safety of medical device materials.ANSI/AAMI/ISO 10993-5:2009, Biological evaluation of medical devices—Part 5: Tests for in vitro cytotoxicity, offers new information on test methods and evaluation criteria for in vitro cytotoxicity. This revised standard is an update to the 1999 edition of the standard.Manufacturers use in vitro cytotoxicity testing to cost-effectively and efficiently evaluate medical device materials for their potential to cause harm. An in vitro cytotoxicity test works by putting a device or material in a solvent at a certain temperature for a period of time. The revised standard contains new information to promote more objectivity in testing.To order, call (877) 249-8226 or visit http://marketplace.aami.org. List price: $70, member price $35 (order code 1099305 or 1099305-PDF, source code PB).